Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose IL-2 in Renal Transplant Recipients
NCT02417870Phase 2Terminated
- Start
- Sep 2015
- Primary completion
- Apr 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in kidney transplant rejection. Started Sep 2015; status: terminated.
02
Drugs
aldesleukin
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02417870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417870.